Log In
Print this Print this

MoxDuo CR (Q8011CR)

  Manage Alerts
Collapse Summary General Information
Company QRxPharma Ltd.
DescriptionControlled-release formulation of oxycodone and morphine
Molecular Target Mu opioid receptor (MOR) (OPRM1)
Mechanism of ActionMu opioid receptor agonist
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsTreat moderate to severe pain
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today